+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID06787014

Comparing Surgery to Remove the Main Tumor Versus Systemic Treatment Alone in Patients With Small Intestinal Neuroendocrine Tumors and Uncurable Spread Across Europe

Led by Insel Gruppe AG, University Hospital Bern · Updated on 2026-03-18

3200

Participants Needed

1

Research Sites

146 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether removing the main tumor improves long-term survival and reduces complications in patients with small intestinal neuroendocrine tumors siNETs that have spread and cannot be cured completely. Current guidelines recommend surgery only for patients with symptoms like intestinal blockage or bleeding, but it is unclear if surgery benefits patients without symptoms. This Europe-wide, retrospective study aims to provide clear evidence on this question by analyzing patient outcomes over 10 years. The study groups patients based on whether they had surgery to remove the primary tumor within six months of diagnosis or received systemic treatment alone. This comparison will help determine the impact of tumor removal in patients who do not show symptoms. The study involves histopathological reviews and collects data from multiple neuroendocrine tumor referral centers across Europe to guide future clinical practice. Participants health outcomes will be tracked for 10 years, focusing on overall survival, disease progression, risks of intestinal blockage or blood flow problems, and surgical risks. Researchers will also evaluate factors that influence long-term survival. This comprehensive follow-up includes monitoring morbidity and mortality related to surgery, aiming to inform treatment guidelines and improve care for patients with metastatic siNETs.

CONDITIONS

Brief Title

Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study

Research Team

E

Eliane Dohner

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here